Naini Thaker's profile photo

Naini Thaker

Bangalore, Mumbai

Assistant Editor at Forbes India

Assistant Editor, @forbesindia

Featured in: Favicon forbesindia.com Favicon forbes.com.br Favicon moneycontrol.com Favicon outlookbusiness.com

Articles

  • Indian Pharma Catching Up To Ozempic, Mounjaro Demand

    2 weeks ago | forbesindia.com | Naini Thaker

    Over time, this leads to a steady reduction in weight. “These drugs are typically administered either via a once-weekly subcutaneous injection or taken orally on a daily basis, depending on the formulation,” adds Dr Agarwal.

  • The India Factor In Dell's AI Playbook

    3 weeks ago | forbesindia.com | Naini Thaker

    While the company has seen workforce reductions globally, its India operations continue to grow in AI R&D, infrastructure solutions, and enterprise services. To counter the slowdown in India’s PC and laptop market, Dell Technologies is shifting its focus toward higher-value services and enterprise solutions.

  • Sun Pharma's Dilip Shanghvi Reveals The Secrets Behind His Leadership Tenets Of Research And Acquisition

    1 month ago | forbesindia.com | Naini Thaker |Suveen Sinha

    If, after all of this, the answer is that it makes sense for us to do that, we consider it. Q. You faced a fair bit of tough times between 2014-15 and 2018, which was also sort of an inflection point for the company. How challenging was it for you then? And how did you turn things around? A few things happened during that period. We did the Ranbaxy acquisition overnight.

  • Dilip Shanghvi Has Built Sun Pharma By Making Bold Bets. And He's Not Done Yet

    1 month ago | forbesindia.com | Naini Thaker

    The acquisitions include the scandal-ridden Ranbaxy Laboratories for $4 billion. At present, pharma stocks are doing well because they have been kept out of US President Donald Trump’s reciprocal tariffs. But uncertainty looms: On April 14, the Trump administration said it had started examining pharmaceutical imports as a possible prelude to tariffs. This comes at a time when Shanghvi’s strategy is becoming bigger and bolder.

  • We See Huge Potential To Impact Millions Of Learners In India: Duolingo's Severin Hacker - Forbes India

    1 month ago | forbesindia.com | Naini Thaker

    Eventually, we found a way to work around the same. Now we have advertising and we have subscription. The subscription has two features—it removes ads and it gives you features that allow you to progress faster in the course. Essentially, users are paying for convenience. We are also adding a second subscription tier, which is Duolingo Max, which has all of our AI-powered features. Q. But to get subscribers, you would have needed quite a bit of marketing…Actually, no.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
977
Tweets
1K
DMs Open
No
Naini Thaker
Naini Thaker @nainithaker
3 May 25

RT @ForbesIndia: .@SunPharma_Live chairman and managing director Dilip Shanghvi reveals the secrets behind his leadership tenets of researc…

Naini Thaker
Naini Thaker @nainithaker
25 Apr 25

RT @ForbesIndia: In a conversation with Forbes India's @nainithaker, @severinhacker, co-founder and CTO of @duolingo, discusses the importa…

Naini Thaker
Naini Thaker @nainithaker
24 Apr 25

RT @ForbesIndia: #WPower2025 | “Nothing can make me quit. I started as a nobody, raised by a single mother, with no favours handed to me. I…